Literature DB >> 23401111

Future cardiovascular risk: Interpreting the importance of increased blood pressure during pregnancy.

Suttira Intapad, Barbara T Alexander.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23401111      PMCID： PMC4392819          DOI： 10.1161/CIRCULATIONAHA.112.000677

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

Review 1.  Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?

Authors:  Vanessa A Rodie; Dilys J Freeman; Naveed Sattar; Ian A Greer
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

Review 2.  Preeclampsia and cardiovascular risk.

Authors:  W Hermes; F Van Kesteren; C J M De Groot
Journal:  Minerva Ginecol       Date:  2012-08

Review 3.  Preeclampsia: the role of angiogenic factors in its pathogenesis.

Authors:  Alice Wang; Sarosh Rana; S Ananth Karumanchi
Journal:  Physiology (Bethesda)       Date:  2009-06

4.  Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.

Authors:  Alan Buchbinder; Baha M Sibai; Steve Caritis; Cora Macpherson; John Hauth; Marshall D Lindheimer; Mark Klebanoff; Peter Vandorsten; Mark Landon; Richard Paul; Menachem Miodovnik; Paul Meis; Gary Thurnau
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

5.  Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health.

Authors:  Lori Mosca; Heidi Mochari-Greenberger; Rowena J Dolor; L Kristin Newby; Karen J Robb
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-02-10

6.  Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort.

Authors:  Morgana L Mongraw-Chaffin; Piera M Cirillo; Barbara A Cohn
Journal:  Hypertension       Date:  2010-06-01       Impact factor: 10.190

7.  Elevated blood pressure in pregnancy and subsequent chronic disease risk.

Authors:  Tuija Männistö; Pauline Mendola; Marja Vääräsmäki; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Anneli Pouta; Eila Suvanto
Journal:  Circulation       Date:  2013-02-12       Impact factor: 29.690

Review 8.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.

Authors:  Sarah D McDonald; Ann Malinowski; Qi Zhou; Salim Yusuf; Philip J Devereaux
Journal:  Am Heart J       Date:  2008-10-02       Impact factor: 4.749

Review 9.  Coronary heart disease in women: battle is won, but the war remains.

Authors:  P K Mehta; N K Wenger
Journal:  Minerva Med       Date:  2007-10       Impact factor: 4.806

10.  Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.

Authors:  Elisabeth B Magnussen; Lars J Vatten; George Davey Smith; Pål R Romundstad
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661
View more
  3 in total

1.  NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase.

Authors:  Minsik Park; Seunghwan Choi; Suji Kim; Joohwan Kim; Dong-Keon Lee; Wonjin Park; Taesam Kim; Jiwon Jung; Jong Yun Hwang; Moo-Ho Won; Sungwoo Ryoo; Seung Goo Kang; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  Exp Mol Med       Date:  2019-02-15       Impact factor: 8.718

2.  Longitudinal Association of Nut Consumption and the Risk of Cardiovascular Events: A Prospective Cohort Study in the Eastern Mediterranean Region.

Authors:  Noushin Mohammadifard; Niloufar Ghaderian; Razieh Hassannejad; Firouzeh Sajjadi; Masoumeh Sadeghi; Hamidreza Roohafza; Jordi Salas-Salvadó; Nizal Sarrafzadegan
Journal:  Front Nutr       Date:  2021-01-21

3.  In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism.

Authors:  Andreia Matos; Alda Pereira da Silva; Maria Clara Bicho; Conceição Afonso; Maria José Areias; Irene Rebelo; Manuel Bicho
Journal:  Obstet Gynecol Int       Date:  2014-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.